FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to an agent for the prevention and treatment of ocular diseases, such as retinal diseases, glaucoma and cataract, to medicine, in particular to the parapharmaceutical industry. Agent for the prevention and treatment of ocular diseases, such as retinal diseases, glaucoma and cataract, including blueberries, ascorbic acid (vitamin C), rutin, DL-alpha-tocopherol acetate (vitamin E), and also contains lutein, zeaxanthin, lycopene, taurine, ginkgo biloba extract, retinol acetate (vitamin A), zinc oxide, chromium picolinate, sodium selenite, microcrystalline cellulose, in a certain amount.
EFFECT: above-described agent has increased efficacy in the prevention and treatment of ocular diseases.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIETARY SUPPLEMENT (VERSIONS) | 2007 |
|
RU2352147C2 |
| AGENT FOR TREATMENT OF EYE DISEASE | 2006 |
|
RU2315612C1 |
| THERAPEUTIC EYE BALSAM | 2012 |
|
RU2512801C1 |
| BIOLOGICALLY ACTIVE FOOD SUPPLEMENT "GLAZNYE" FOR TREATMENT AND PROPHYLAXIS OF OPHTHALMIC DISEASES | 2001 |
|
RU2197258C1 |
| METHOD FOR APPLYING COMPLEX TREATMENT OF GLAUCOMA | 2000 |
|
RU2176501C2 |
| METHOD OF TREATING "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION | 2012 |
|
RU2489146C1 |
| NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT | 2019 |
|
RU2806096C2 |
| METHOD FOR INHIBITING THE PROGRESSION OF THE "DRY" FORM OF AGE-RELATED MACULAR DEGENERATION IN ELDERLY PATIENTS | 2020 |
|
RU2755890C1 |
| COMPOSITION FOR PREVENTING OR TREATING EYE DISEASES, CONTAINING S-ALLYL-L-CYSTEIN AS ACTIVE INGREDIENT, AND PHARMACEUTICAL PREPARATION CONTAINING IT | 2013 |
|
RU2605618C2 |
| METHODS OF ORAL HEALTH PROMOTION IN ANIMALS | 2005 |
|
RU2430629C2 |
